Spark reports Phase I/II bleeding rate data for SPK-9001 in hemophilia B

Data published in the New England Journal of Medicine from a Phase I/II trial in 10 hemophilia B patients showed that a single IV dose of gene

Read the full 272 word article

User Sign In